Skip to content

The effect of SF396 in the transplant model of psoriasis

The effect of SF396 in the transplant model of psoriasis - The effect of SF296 in the mouse transplant modelof psoriasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34046
Enrollment
10
Registered
2010-05-25
Start date
2010-05-26
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

None listed

Sponsors

Dr. August Wolff GmbH & Co.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Mild to moderate psoriasis vulgaris

Exclusion criteria

Exclusion criteria: Volunteers can not be taking drugs systemically, including immune-modifiers for other diseases. Volunteers cannot be be undergoing UV/light therapy Volunteers should not show Kobner phenomenon at wound sites.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)